Soliance on Givaudan's radar

By Michelle Yeomans

- Last updated on GMT

Soliance on Givaudan's radar

Related tags Cosmetics

As it aims to step further into the skin care segment, Givaudan is in exclusive negotiations to acquire French manufacturer, Soliance.

France-based active ingredient specialist Soliance is a division of Agro-Industrie Recherches & Dévelopments and could see 100% of the shares ​and its units go to Givaudan.

If all goes to plan, Givaudan says it will be carrying out the transaction with cash on hand with an aim to build upon its existing active cosmetic ingredients business and enhance its current portfolio, including the fragrance division's work with natural molecules.

However, the producer of fragrances and flavours based just outside Geneva, has yet to disclose the price it would likely pay for Soliance, but has said that the latter's sales would have added about €25 million Swiss francs to its' 2013 revenue.

Soliance currently has two sites in France, located in Pomacle and Ile Grande where it uses vegetables, micro-organisms and micro-algae for cosmetics, including self-tanning lotions and skin creams.

First acquisition since 2006

If the acquisition all goes to plan, it will be Givaudan's first since 2006, when it bought flavours-and-fragrance maker Quest International.

Soliance represents Givaudan’s first acquisition since that of Quest," ​reiterates Gilles Andrier, Givaudan's CEO.

"Its current portfolio of active cosmetic ingredients and strong process development and research capabilities fit well into the five strategic pillars of Givaudan,” ​he adds.

Michael Carlos, president of Givaudan’s fragrance division, added that the brand expects Soliance to become an integral part of its' fragrance division and to bring significant contributions over the next few years, particularly in research and development area.

"Soliance has a strong track record of identifying natural molecules, which can bring value to our customers and to their consumers​,” he said.

The transaction is expected to close in the second quarter of 2014, subject to the customary closing approvals and conditions which includes consultations with the employee representative bodies.

Related topics Business & Financial Skin Care

Related news

Show more

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers